Invesco Ltd.
32.09USD
-0.2500 (-0.77%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.74▲ | $0.67 | 4 | 5 |
| Next quarter | $0.79▲ | $0.72 | 3 | 6 |
| Current year | $2.81▲ | $2.59 | 8 | 5 |
| Next year | $3.26▲ | $2.97 | 9 | 4 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.66 | $0.71 | +0.05 (+7.2%) |
| 2026-03-31 | $0.58 | $0.57 | -0.01 (-1.2%) |
| 2025-12-31 | $0.58 | $0.62 | +0.04 (+7.1%) |
| 2025-09-30 | $0.44 | $0.61 | +0.17 (+37.7%) |
394 ratings from 22 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $37 $39 | Aug 13, 2026 |
| Evercore ISI Group | Maintained | In-Line | $33 $35 | Aug 10, 2026 |
| JP Morgan | Maintained | Neutral | $29 $29.5 | Jul 29, 2026 |
| RBC Capital | Maintained | Outperform | $33 $35 | Jul 29, 2026 |
| Barclays | Maintained | Equal-Weight | $31 $32 | Jul 29, 2026 |
| RBC Capital | Maintained | Outperform | $31 $33 | Jul 23, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $29 $30 | Jul 17, 2026 |
| Barclays | Maintained | Equal-Weight | $26 $31 | Jul 14, 2026 |
| Evercore ISI Group | Maintained | In-Line | $31 $32 | Jul 10, 2026 |
| RBC Capital | Reiterated | Outperform | $31 | Jul 2, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $28 $29 | Jun 26, 2026 |
| Evercore ISI Group | Maintained | In-Line | $28 $31 | Jun 8, 2026 |
| TD Cowen | Maintained | Buy | $32 $33 | Jun 8, 2026 |
| JP Morgan | Maintained | Neutral | $25 $27.5 | Apr 29, 2026 |
| TD Cowen | Maintained | Buy | $27 $32 | Apr 29, 2026 |
| Goldman Sachs | Maintained | Neutral | $27 $30 | Apr 29, 2026 |
| Evercore ISI Group | Maintained | In-Line | $27 $28 | Apr 29, 2026 |
| Barclays | Maintained | Equal-Weight | $24 $26 | Apr 29, 2026 |
| JP Morgan | Maintained | Neutral | $30 $25 | Apr 24, 2026 |
| Barclays | Maintained | Equal-Weight | $29 $24 | Apr 17, 2026 |
| Evercore ISI Group | Maintained | In-Line | $29 $27 | Apr 10, 2026 |
| BMO Capital | Maintained | Outperform | $32 $28 | Apr 10, 2026 |
| Goldman Sachs | Maintained | Neutral | $30 $27 | Apr 7, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $28 $26 | Apr 1, 2026 |
| Goldman Sachs | Maintained | Neutral | $29.5 $30 | Feb 12, 2026 |
94 filings from 22 insiders · 0 buy / 0 sell over 6m
Officers and directors of IVZ, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| DUKES LAURA ALLISONOfficer, Chief Financial Officer | Gift | 7.6k | — | — | Sep 4, 2026 |
| DUKES LAURA ALLISONOfficer, Chief Financial Officer | Sell | 31.1k | $33.16 | $1.03M | Sep 4, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 20.8k | — | — | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 19.2k | — | — | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 25.5k | — | — | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Tax | 9.8k | $32.78 | $320k | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Grant | 20.8k | — | — | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Tax | 9.0k | $32.78 | $296k | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Grant | 19.2k | — | — | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Tax | 12.0k | $32.78 | $393k | Aug 31, 2026 |
| Butcher StephanieOfficer, Senior Managing Director | Grant | 25.5k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 22.6k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 22.4k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 11.9k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | ExerciseRestricted Stock Units | 13.5k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | Grant | 22.6k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | Tax | 10.4k | $32.78 | $340k | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | Grant | 22.4k | — | — | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | Tax | 5.5k | $32.78 | $181k | Aug 31, 2026 |
| Sharp Douglas JOfficer, Senior Managing Director | Grant | 11.9k | — | — | Aug 31, 2026 |
No analyst notes on IVZ yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 3 | 9 | 0 | 0 | Hold2.62 |
| 1 mo ago | 1 | 3 | 9 | 0 | 0 | Hold2.62 |
| 2 mo ago | 1 | 3 | 8 | 0 | 0 | Hold2.58 |